Travaux scientifiques

Prof. Dr. Hüseyin Mertsoylu

113 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Chemoradiotherapy-induced Cochlear Toxicity

    International Journal of Scientific Research and Management (IJSRM), 2019

    DOI 10.18535/ijsrm/v7i9.mp03 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  2. Clinicohistopathological features and treatment outcomes in testicular lymphomas: A single center experience

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e16533 Source : ORCID

  3. Clinicohistopathological features and treatment outcomes of neuroendocrine tumors: a single center experience

    Cukurova Medical Journal, 2018

    DOI 10.17826/cumj.335741 Texte intégral en libre accèsSource : ORCID

  4. A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study)

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.4_suppl.26 5 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  5. Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer

    Lung Cancer, 2018

    DOI 10.1016/j.lungcan.2018.04.016 PMID 29858023 10 citations (Europe PMC) Source : ORCID

  6. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide

    Journal of Neuro-Oncology, 2018

    DOI 10.1007/s11060-018-2879-4 PMID 29696530 21 citations (Europe PMC) Source : ORCID

  7. Risk factors for fatal pulmonary hemorrhage following concurrent chemoradiotherapy in stage 3B/C squamous-cell lung carcinoma patients

    Journal of Oncology, 2018

    DOI 10.1155/2018/4518935 PMID 30515211 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  8. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy

    International Journal of Gynecological Cancer, 2018

    DOI 10.1097/igc.0000000000001345 PMID 30247248 17 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  9. COMBINATION OF OxALIPLATIN, CAPECITABINE,t r a s t u z u m a b a n d c h e m o r a d io t h e r a p y INPATIENTS WITH GASTRIC CANCER

    AYBU AVESIS, 2018

    Source : OpenAlex

  10. Non-small-cell lung cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study

    Ortadoğu Tıp Dergisi, 2017

    DOI 10.21601/ortadogutipdergisi.343275 Texte intégral en libre accèsSource : OpenAlex

  11. A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; A hospital-based retrospective case series study

    Journal of B.U.ON., 2017

    PMID 29332358 21 citations (OpenAlex) Source : ORCID

  12. Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

    Journal of Thoracic Oncology, 2017

    Source : ORCID

  13. The impact of stereotactic radiotherapy to metastatic site on systemic treatment decision in oligometastatic breast cancer patients

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e12564 1 citation (OpenAlex) Source : ORCID

  14. P1.07-010 Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2016.11.921 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  15. Prognostic and predictive role of FOXP3 positive tumor infiltrating lymphocytes (TILs) in curatively resected non small cell lung cancer other than stage IA

    Journal of Oncological Sciences, 2017

    DOI 10.1016/j.jons.2017.07.002 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  16. P3.08-001 Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1705 Texte intégral en libre accèsSource : OpenAlex

  17. A study on basic demographic and disease characteristics of the cancer diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa: a hospital-based retrospective case series study

    Kocaeli Üniversitesi - AVESİS, 2017

    Source : OpenAlex

  18. Febrile neutropenia due to H1N1 infection: Rare entity

    Journal of Oncological Sciences, 2016

    DOI 10.1016/j.jons.2015.11.001 Texte intégral en libre accèsSource : OpenAlex

  19. Prognostic value of procalcitonin in infection-related mortality of cancer patients.

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2016

    PMID 27569098 2 citations (Europe PMC) Source : ORCID

  20. 110P: Predictive and prognostic role of T-regulatory cells in resected non-small cell lung cancer

    Journal of Thoracic Oncology, 2016

    DOI 10.1016/s1556-0864(16)30223-4 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  21. A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastro-esophageal junction cancer (TOXAG study)

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.4_suppl.tps182 21 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  22. Prognostic value of procalcitonin in infection-related mortality of cancer patients

    Journal of B.U.ON., 2016

    Source : ORCID

  23. Acute fatal interstitial lung disease in two cases under treatment of crizotinib

    Clinical Case Reports and Reviews, 2016

    DOI 10.15761/ccrr.1000250 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  24. Can primary tumor localization predict the which patient will have benefit from addition of taxanes to platin-5-FU based regimens in metastatic gastric cancer. Multi center retrospective analysis from Turkey, Society of Turkish Oncology Group study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15030 Source : OpenAlex

  25. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience.

    Medical science monitor : international medical journal of experimental and clinical research, 2015

    DOI 10.12659/msm.892730 PMID 25731741 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  26. Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

    Medical oncology (Northwood, London, England), 2015

    DOI 10.1007/s12032-014-0476-8 PMID 25572818 3 citations (Europe PMC) Source : ORCID

  27. CONCURRENT CHEMORADIOTHERAPY WITH VINORELBINE PLUS SPLIT-DOSE CISPLATIN IN INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER

    Annals of Oncology, 2015

    DOI 10.1093/annonc/mdv049.10 Texte intégral en libre accèsSource : ORCID

  28. High Pretreatment Neutrophil-Lymphocyte Ratio: A Poor Prognostic Factor for Stage III Non-Small Cell Lung Cancer Patients

    Journal of Thoracic Oncology, 2015

    Source : ORCID

  29. PROGNOSTIC ROLE OF T-REGULATORY CELLS IN COMPLETELY RESECTED EARLY STAGE NON-SMALL CELL LUNG CARCINOMA

    Annals of Oncology, 2015

    DOI 10.1093/annonc/mdv048.11 Texte intégral en libre accèsSource : ORCID

  30. Procalcitonin as a biomarker for infection-related mortality in cancer patients

    Current Opinion in Supportive and Palliative Care, 2015

    DOI 10.1097/spc.0000000000000142 PMID 25872114 9 citations (Europe PMC) Source : ORCID

  31. Prognostic Role of fox-p3 Positive T-Regulatory Cells in Curatively Resected NSCLC Other than Stage IA

    Journal of Thoracic Oncology, 2015

    Source : ORCID

  32. Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases

    Molecular and Clinical Oncology, 2015

    DOI 10.3892/mco.2014.456 PMID 25798275 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  33. Prolonged use of bevacizumab may cause extensive coronary artery thrombosis.

    PubMed, 2014

    PMID 24965427 Source : OpenAlex

  34. Primary Extranodal Non-Hodgkin's Lymphoma: Clinicopathological Features, Survival and Treatment Outcome in Two Cancer Centers of Southern Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.17.7207 PMID 25227815 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  35. Lack of Prognostic Significance of C-erbB-2 Expression in Low- and High- grade Astrocytomas

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.3.1333 PMID 24606461 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  36. Gemcitabine + platinum combination chemotherapy in patients with metastatic cancer who suffer from severe and irreversible hepatic impairment: a single center experience.

    Hepato-gastroenterology, 2014

    PMID 25713885 Source : ORCID

  37. Malignant pleural mesothelioma: a single-center experience in Turkey.

    Medical science monitor : international medical journal of experimental and clinical research, 2014

    DOI 10.12659/msm.890020 PMID 24842043 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  38. Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel.

    International urology and nephrology, 2014

    DOI 10.1007/s11255-014-0664-7 PMID 24526335 19 citations (Europe PMC) Source : ORCID

  39. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: A curative approach

    International Journal of Radiation Oncology Biology Physics, 2014

    DOI 10.1016/j.ijrobp.2013.12.017 PMID 24495594 23 citations (Europe PMC) Source : ORCID

  40. Gemcitabine plus Platinum Combination Chemotherapy in Patients with Metastatic Cancer who suffer from Severe and Irreversible Hepatic Impairment: A Single Center Experience

    Hepato-Gastroenterology, 2014

    DOI 10.5754/hge14588 Source : ORCID

  41. Prolonged use of bevacizumab may cause extensive coronary artery thrombosis

    Journal of B.U.ON., 2014

    Source : ORCID

  42. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer

    Journal of B.U.ON., 2014

    PMID 24965406 10 citations (OpenAlex) Source : ORCID

  43. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.

    PubMed, 2013

    PMID 23613414 7 citations (Europe PMC) Source : OpenAlex

  44. Acute infusion reactions to chemotherapeutic drugs: A single institute experience

    Journal of B.U.ON., 2013

    Source : ORCID

  45. MULTIMODALITY TREATMENT FOR THYMOMA AND THYMIC CARCINOMA: RESULTS OF A SINGLE CENTER EXPERIENCE

    Journal of Thoracic Oncology, 2013

    Source : ORCID

  46. PATHOLOGIC SUBGROUP ANALYSIS IN PATIENTS WHO WERE DIAGNOSED AS NON-SMALL CELL LUNG CARCINOMA AND ANALYSIS OF ITS EFFECT TOGETHER WITH BASIC DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS ON SURVIVAL PARAMETERS

    Journal of Thoracic Oncology, 2013

    Source : ORCID

  47. The Evaluation of Doxorubicin Cardiomyopathy By Signal Averaged Electrocardiography

    Cukurova Medical Journal, 2013

    Source : ORCID

  48. The clinical impact of oncological patients with solitary bone lesions detected on F-18 FDG PET/CT scans

    European Journal of Nuclear Medicine and Molecular Imaging, 2013

    Source : ORCID

  49. Doksorubisin Kardiyotoksisitesinin Sinyal Ortalamali Elektrokardiyografi İle Değerlendirilmesi

    DergiPark (Istanbul University), 2013

    Texte intégral en libre accèsSource : OpenAlex

  50. Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study

    Medical Oncology, 2012

    DOI 10.1007/s12032-012-0254-4 PMID 22729367 8 citations (Europe PMC) Source : OpenAlex